Counterregulatory response to hypoglycemia during a hypoglycemic clamp in people with type 2 diabetes treated with tirzepatide

IntroductionTo evaluate counterregulatory hormonal responses during a hypoglycemic clamp with tirzepatide.MethodsParticipants with type 2 diabetes (N=42) were randomized to tirzepatide (15 mg) or placebo for 12 weeks in a crossover design, with a wash-out period of 8–10 weeks. The primary objective...

Descripció completa

Dades bibliogràfiques

Autors principals:	Thomas R. Pieber, Eva Svehlikova, Shweta Urva, Axel Haupt, Chunmei Zhou, Tamer Coskun, Vera Höller, Gabriele Fluhr, Chrisanthi A. Karanikas, Zvonko Milicevic, Edward John Pratt
Format:	Artigo
Idioma:	Inglês
Publicat:	Frontiers Media S.A. 2025-09-01
Col·lecció:	Frontiers in Endocrinology
Matèries:	type 2 diabetes tirzepatide counterregulatory response hypoglycemia clinical trial
Accés en línia:	https://www.frontiersin.org/articles/10.3389/fendo.2025.1627947/full
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!